ANNOUNCEMENT

Take a look at the MedCity ENGAGE program, with expert speakers from leading organizations. Reserve your place today.

Topic: pain medication

FDA staff says Zogenix painkiller has abuse risks

FDA staff says Zogenix painkiller has abuse risks

December 5, 2012 9:34 am by | 0 Comments

(Reuters) - Drug reviewers said a painkiller developed by Zogenix Inc could possibly be abused more than currently available hydrocodone combination products.Zogenix's painkiller Zohydro is a single-entity product containing hydrocodone ... Read more
Study: Opiod addiction risk low with proper use

Study: Opiod addiction risk low with proper use

November 3, 2012 11:15 am by | 3 Comments

NEW YORK (Reuters Health) - Fewer than five percent of patients prescribed narcotics to treat chronic pain become addicted to the drugs, according to a new analysis of past research.The ... Read more
Improving patient safety has to involve stopping errors with infusion pumps for post-op pain

Improving patient safety has to involve stopping errors with infusion pumps for post-op pain

September 25, 2012 8:26 am by | 1 Comments

Patient-controlled infusion pumps have been in use for 40 years, and while incremental improvements have been made, error rates remain unacceptably high -- these preventable mistakes must be avoided for ... Read more
Watson issues voluntary nationwide recall of superpotent painkillers

Watson issues voluntary nationwide recall of superpotent painkillers

September 21, 2012 4:02 pm by | 0 Comments

Watson Laboratories, Inc. today issued a voluntary nationwide recall for two lots of Hydrocodone Bitartrate and APAP Tablets, USP 10 mg/500 mg. A customer complaint was received for tablets that ... Read more
After heart attacks, pain drugs’ risks seem to last

After heart attacks, pain drugs’ risks seem to last

September 21, 2012 1:26 pm by | 0 Comments

NEW YORK (Reuters Health) - Common painkillers like ibuprofen and naproxen are considered risky for people who've had a heart attack. And now a large study suggests those risks do ... Read more
Clinical-stage Adynxx looks for success treating pain as a disease rather than a symptom

Clinical-stage Adynxx looks for success treating pain as a disease rather than a symptom

September 7, 2012 10:24 am by | 0 Comments

Despite the many avenues for treating pain these days, the Institute of Medicine estimates that it costs the U.S. a whopping $635 billion annually in medical charges and lost productivity. ... Read more
Nucynta gets FDA OK for diabetic neuropathy

Nucynta gets FDA OK for diabetic neuropathy

August 29, 2012 1:14 pm by | 0 Comments

WASHINGTON (Reuters) - Johnson & Johnson unit Janssen Pharmaceuticals said on Wednesday it received U.S. regulatory approval for a wider use of its painkiller Nucynta ER, for nerve damage brought ... Read more